Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease
Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease
The main objective of this study is to evaluate the effect of 3 months of "Snoezelen-type"
 multi-sensory care sessions on NeuroPsychiatric Inventory Questionnaire (NPI-Q) scores for
 patients with Alzheimer's-type neurodegenerative disease.
The secondary objectives of this study are to study the following elements in relationship to
 the implementation of a "Snoezelen-type" multi-sensory care strategy for patients with
 Alzheimer's-type neurodegenerative disease:

 A. to evaluate the effects on NPI-Q scores at 1 month, 6 months and 12 months .

 B. evaluate the effects on quality of life (questionnaire QOL-AD) at 0 and 12 months.

 C. assess changes in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation
 Inventory (CMAI) questionnaire over 0, 1, 3, 6 and 12 months.

 D. assess changes in drug consumption (anxiolytics, antidepressants, hypnotics,
 neuroleptics)over the study period
Inclusion Criteria:

 -  The patient's legal representative must have given his/her informed and signed consent
 (or the patient if he/she is judged competent)

 -  The patient must be insured or beneficiary of a health insurance plan

 -  Alzheimer's-type neurodegenerative pathology

 -  The patient has been living in the participating center for > 2 months

 Exclusion Criteria:

 -  The patient's legal representative refuses to sign the consent (or the patient if
 he/she is judged competent)

 -  It is impossible to correctly inform the patient's legal representative

 -  The patient has already has Snoezelen-therapy